Literature DB >> 23401258

Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice.

Arne Dikkers1, Jan Freak de Boer, Wijtske Annema, Albert K Groen, Uwe J F Tietge.   

Abstract

UNLABELLED: Biliary lipid secretion plays an important role in gallstone disease and reverse cholesterol transport (RCT). Using Sr-bI/Abcg5 double knockout mice (dko), the present study investigated the differential contribution of two of the most relevant transporters: adenosine triphosphate (ATP)-binding cassette subfamily G member 5 and 8 (ABCG5/G8) and scavenger receptor class B type I (SR-BI) to sterol metabolism and RCT. Plasma cholesterol levels increased in the following order, mainly due to differences in high density lipoprotein (HDL): Abcg5 ko < wild type < Sr-bI/Abcg5 dko < Sr-bI ko. Liver cholesterol content was elevated in Sr-bI ko only (P < 0.05). In Sr-bI/Abcg5 dko plasma plant sterols were highest, while hepatic plant sterols were lower compared with Abcg5 ko (P < 0.05). Under baseline conditions, biliary cholesterol secretion rates decreased in the following order: wild type > Sr-bI ko (-16%) > Abcg5 ko (-75%) > Sr-bI/Abcg5 dko (-94%), all at least P < 0.05, while biliary bile acid secretion did not differ between groups. However, under supraphysiological conditions, upon infusion with increasing amounts of the bile salt tauroursodeoxycholic acid, Abcg5 became fully rate-limiting for biliary cholesterol secretion. Additional in vivo macrophage-to-feces RCT studies demonstrated an almost 50% decrease in overall RCT in Sr-bI/Abcg5 dko compared with Abcg5 ko mice (P < 0.01).
CONCLUSION: These data demonstrate that (1) SR-BI contributes to ABCG5/G8-independent biliary cholesterol secretion under basal conditions; (2) biliary cholesterol mass secretion under maximal bile salt-stimulated conditions is fully dependent on ABCG5/G8; and (3) Sr-bI contributes to macrophage-to-feces RCT independent of Abcg5/g8.
Copyright © 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401258     DOI: 10.1002/hep.26316

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE.

Authors:  Quan Yuan; Jinghua Bie; Jing Wang; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2013-08-29       Impact factor: 5.922

Review 2.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice.

Authors:  Jianing Li; Sonja S Pijut; Yuhuan Wang; Ailing Ji; Rupinder Kaur; Ryan E Temel; Deneys R van der Westhuyzen; Gregory A Graf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

4.  E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver.

Authors:  Qiuwen Lai; Albert Giralt; Cédric Le May; Lianjun Zhang; Bertrand Cariou; Pierre-Damien Denechaud; Lluis Fajas
Journal:  JCI Insight       Date:  2017-05-18

5.  GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice.

Authors:  Yuhuan Wang; Kai Su; Nadezhda S Sabeva; Ailing Ji; Deneys R van der Westhuyzen; Fabienne Foufelle; Xia Gao; Gregory A Graf
Journal:  Metabolism       Date:  2015-08-15       Impact factor: 8.694

6.  Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.

Authors:  Arne Dikkers; Wijtske Annema; Jan Freark de Boer; Jahangir Iqbal; M Mahmood Hussain; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2014-02-07       Impact factor: 5.922

7.  Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport in vivo.

Authors:  Yanhong Si; Ying Zhang; Xiaofeng Chen; Lei Zhai; Guanghai Zhou; Ailing Yu; Haijun Cao; Qin Shucun
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-31

8.  Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.

Authors:  Yan Xie; Ho Yee Joyce Fung; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Rosanne M Crooke; Mark J Graham; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2014-01-28       Impact factor: 5.922

Review 9.  New developments in selective cholesteryl ester uptake.

Authors:  Jason M Meyer; Gregory A Graf; Deneys R van der Westhuyzen
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

Review 10.  Liver X receptors at the intersection of lipid metabolism and atherogenesis.

Authors:  Stephen D Lee; Peter Tontonoz
Journal:  Atherosclerosis       Date:  2015-07-02       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.